Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26975Recruiting
Randomised, single-blind trial of levocetirizine and fluticasone in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Erasmus MC. Primary endpoint: Percentage of nose and eye symptom-free days. Started Sep 2012; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26975.